Royal Caribbean Cruises Ltd. (NYSE:RCL) shares moved down -0.35% in last trading session and ended the day at $94.02. RCL Gross Margin is 37.10% and its has a return on assets of 2.70%. Royal Caribbean Cruises Ltd. (NYSE:RCL) quarterly performance is 12.38%.
On November 13, 2015, Royal Caribbean Cruises Ltd. (NYSE:RCL) entered into credit agreements for the financing of the fourth and fifth Quantum-class ships for Royal Caribbean International which are scheduled for delivery in the second quarter of 2019 and fourth quarter of 2020, respectively. Each agreement makes available to Royal Caribbean Cruises Ltd. an unsecured US dollar-denominated term loan guaranteed 95% by Euler Hermes Deutschland AG (“Hermes”), the official export credit agency of Germany. The maximum amount of each facility is equal to the US dollar equivalent of 80% of the vessel purchase price plus 100% of the premium payable to Hermes.
Meridian Bancorp, Inc. (NASDAQ:EBSB) ended the last trading day at $14.63. Company weekly volatility is calculated as 1.71% and price to cash ratio as 3.01. Meridian Bancorp, Inc. (NASDAQ:EBSB) showed a weekly performance of 1.95%.
On 20 November, Full Circle Capital Corporation (NASDAQ:FULL) shares moved down -2.03% and was closed at $2.90. FULL EPS growth in last 5 year was -8.65%. Full Circle Capital Corporation (NASDAQ:FULL) year to date (YTD) performance is -35.84%.
Full Circle Capital Corp (NASDAQ:FULL) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Friday, MarketBeat reports.
Identiv, Inc. (NASDAQ:INVE) shares moved up 1.50% in last trading session and ended the day at $2.70. INVE Gross Margin is 42.10% and its has a return on assets of -29.40%. Identiv, Inc. (NASDAQ:INVE) quarterly performance is -40.13%.
Identiv, Inc. (NASDAQ:INVE) announced that, on November 17, 2015, the Company received a letter from the NASDAQ Listing Qualifications Staff (the “Staff”) of The NASDAQ Stock Market LLC (“NASDAQ”) notifying the Company that since it had not filed its Form 10-Q for the quarter ended September 30, 2015, and because it remains delinquent in filing the Company’s Form 10-Q for the quarter ended June 30, 2015 and the Form 10-Q for the quarter ended March 31, 2015, the Staff has determined that the Company is non-compliant with the Nasdaq Listing Rule 5250(c)(1).
Kura Oncology, Inc. (NASDAQ:KURA) caters to the Healthcare space. Its weekly performance is -0.96%. On the last day of trading company shares ended up at $8.25. Kura Oncology, Inc. (NASDAQ:KURA) distance from 50-day simple moving average (SMA50) is -2.29%.
Kura Oncology, Inc. (NASDAQ:KURA), announced that Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, presented an overview of the company at 2:40 p.m. GMT (6:40 a.m. PST) on Thursday, November 19, at the Jefferies 2015 Global Healthcare Conference in London.